Many viral diseases tend to become chronic – including infections with the HI virus. In persons affected, the immune response is not sufficient to eliminate the virus permanently. Scientists at the University of Bonn have now identified an immune factor which is partially responsible for this. Their results give rise to hopes for new therapeutic approaches. The work, which included researchers from the University of Cologne and the Technical University of Munich, is being published in the renowned journal "Nature Immunology."
The HI virus triggers the immunodeficiency disease AIDS. The infection has a chronic course – the immune system is not able to get rid of the pathogen. This is due among other things to the fact that the virus directly attacks and destroys certain immune cells known as helper T cells.
Prof. Dr. Joachim L. Schultze and Dr. Marc Beyer (from left) from LIMES Institute of University of Bonn.
(c) Photo: Barbara Frommann/Uni Bonn
However, many helper T cells are not affected by the virus at all. Nonetheless their function is impaired in the case of AIDS. Normally, helper T cells secrete inflammatory messengers during an infection. As a result of this chemical distress call, killer T cells (the body's own defense troops) become ready to fight and are guided to the site. By contrast, in AIDS and other chronic infections, the helper T cells remain silent. But why is that?
To answer this question, the researchers initially analyzed which genes in the silent helper cells of HIV patients are active. Result: In chronic inflammation, the immune function of the helper T cells is inhibited by various signaling pathways. These signaling pathways in turn are apparently controlled by a single molecule known as tumor necrosis factor (TNF).
This factor appears to be responsible for the weak immune response. "We investigated mice suffering from a chronic viral infection similar to an HIV infection and inactivated the TNF molecule in them," explains Dr. Marc Beyer from Life and Medical Sciences Institute (LIMES) of the University of Bonn. "As a result, the helper T cells worked normally once again. After ten days, the animals had completely eliminated the virus; they were healthy."
Misdirected protective function
Paradoxically, the tumor necrosis factor has exactly the opposite effect in acute viral attacks: It brings the immune system up to full speed and additionally ensures that cells infected with the virus commit suicide. "Therefore, in an acute infection, large quantities of TNF are formed very rapidly," says Dr. Zeinab Abdullah from the Institute of Experimental Immunology at the University Hospital Bonn. "In chronic infections, on the other hand, the body secretes small amounts of TNF over a long period of time. This appears to cause the helper T cells to shut down to some extent."
The researchers suspect that this is a protective mechanism. A prolonged strong immune reaction can in particular destroy healthy tissues as well – with life-threatening consequences. TNF could act as a type of emergency brake which prevents this. Exactly what the tumor necrosis factor does on a molecular level is still largely unknown. The scientists involved now want to examine this question in detail.
The results may establish new therapeutic options in the medium term. Thus there are drugs which inhibit the effect of TNF. These TNF blockers are used in the treatment of autoimmune diseases such as rheumatism, for example. They are to prevent defense cells from attacking the body itself. "Among other things, we want to investigate what effects these drugs have in rheumatism patients who are additionally suffering from a chronic viral infection," says Marc Beyer.
Publication: Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection; Nature Immunology; DOI: 10.1038/ni.3399
Media contact information:
Dr. Marc Beyer
University of Bonn
Dr. Zeinab Abdullah
Institute of Experimental Immunology
University Hospital Bonn
Johannes Seiler | idw - Informationsdienst Wissenschaft
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences